EFORL-R Stock Overview
Engages in the distribution of medical devices and equipment in Thailand.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
E for L Aim Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿0.17 |
| 52 Week High | ฿0.41 |
| 52 Week Low | ฿0.14 |
| Beta | 1.02 |
| 11 Month Change | -10.53% |
| 3 Month Change | -10.53% |
| 1 Year Change | 6.25% |
| 33 Year Change | -85.83% |
| 5 Year Change | -66.00% |
| Change since IPO | -92.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| EFORL-R | TH Healthcare | TH Market | |
|---|---|---|---|
| 7D | 0% | -1.4% | -1.3% |
| 1Y | 6.3% | -8.3% | -13.9% |
Return vs Industry: EFORL-R exceeded the TH Healthcare industry which returned -8.3% over the past year.
Return vs Market: EFORL-R exceeded the TH Market which returned -13.9% over the past year.
Price Volatility
| EFORL-R volatility | |
|---|---|
| EFORL-R Average Weekly Movement | 8.8% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TH Market | 8.9% |
| 10% least volatile stocks in TH Market | 2.2% |
Stable Share Price: EFORL-R has not had significant price volatility in the past 3 months.
Volatility Over Time: EFORL-R's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of TH stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Preecha Nuntnarumit | www.eforl-aim.com |
E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand. The company offers clinical hematology, microscopy, chemistry, immunology, and microbiology related products. It also offers various equipment for medical devices.
E for L Aim Public Company Limited Fundamentals Summary
| EFORL-R fundamental statistics | |
|---|---|
| Market cap | ฿679.74m |
| Earnings (TTM) | ฿11.89m |
| Revenue (TTM) | ฿1.27b |
57.2x
P/E Ratio0.5x
P/S RatioIs EFORL-R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EFORL-R income statement (TTM) | |
|---|---|
| Revenue | ฿1.27b |
| Cost of Revenue | ฿839.49m |
| Gross Profit | ฿431.16m |
| Other Expenses | ฿419.27m |
| Earnings | ฿11.89m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.003 |
| Gross Margin | 33.93% |
| Net Profit Margin | 0.94% |
| Debt/Equity Ratio | 76.4% |
How did EFORL-R perform over the long term?
See historical performance and comparison